MindWalk Holdings (HYFT) Income from Continuing Operations (2020 - 2026)
MindWalk Holdings' (HYFT) quarterly Income from Continuing Operations came in at -$3.4 million in Q2 2026, up 75.78% year-over-year from -$1.9 million in Q2 2025, and down 28.77% quarter-over-quarter from -$2.7 million in Q1 2026.
Analysis
MindWalk Holdings (HYFT) Income from Continuing Operations (2020 - 2026) Analysis & Trends
MindWalk Holdings (HYFT) has reported Income from Continuing Operations for 7 consecutive years, with -$3.4 million the latest figure, recorded in Q2 2026.
- On a quarterly basis, Income from Continuing Operations rose 75.78% year-over-year to -$3.4 million in Q2 2026; TTM through Apr 2026 was -$3.1 billion, a 24.05% increase from a year earlier, with the FY2026 full-year figure at -$11.2 million, up 62.47% from the prior year.
- Income from Continuing Operations was -$3.4 million for Q2 2026 at MindWalk Holdings, down from -$2.7 million in the prior quarter.
- Over five years, Income from Continuing Operations peaked at -$2.0 million in Q4 2025 and troughed at -$4.0 billion in Q3 2024.
- A 5-year average of -$693.5 million and a median of -$5.7 million in 2022 frame the typical range for Income from Continuing Operations.
- Across the five-year window, Income from Continuing Operations plunged 40254.8% in 2023 and soared 99.84% in 2024, its largest moves.
- Over 5 years, Income from Continuing Operations stood at -$5.5 million in 2022, then tumbled by 39915.91% to -$2.2 billion in 2023, then soared by 99.84% to -$3.5 million in 2024, then jumped by 43.42% to -$2.0 million in 2025, then tumbled by 72.81% to -$3.4 million in 2026.
- The last three Income from Continuing Operations figures came in at -$3.4 million (Q2 2026), -$2.7 million (Q1 2026), and -$2.0 million (Q4 2025), per Business Quant data.
Peer Set
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Income (Continuing) (Qtr) |
|---|---|---|---|---|---|
| 1 | Iqvia Holdings | 44.06 Bn | 42.11 Bn | 1.44 Bn | 241.00 Mn |
| 2 | Medpace Holdings | 16.50 Bn | 16.00 Bn | 201.64 Mn | 121.36 Mn |
| 3 | Charles River Laboratories International | 13.77 Bn | 13.62 Bn | 452.07 Mn | -760,000.00 |
| 4 | Icon | 12.62 Bn | 11.69 Bn | 479.29 Mn | 111.81 Mn |
| 5 | Fortrea Holdings | 1.68 Bn | 1.51 Bn | 139.20 Mn | -13.20 Mn |
| 6 | Evotec SE | 661.34 Mn | 235.46 Mn | - | - |
| 7 | Ginkgo Bioworks Holdings | 442.79 Mn | 358.26 Mn | 18.44 Mn | -57.32 Mn |
| 8 | Champions Oncology | 72.49 Mn | 72.62 Mn | 7.03 Mn | -667,000.00 |
| 9 | MindWalk Holdings | 61.66 Mn | 53.38 Mn | 1.82 Mn | -3.43 Mn |
| 10 | VivoSim Labs | 1.47 Mn | 1.47 Mn | - | -2.74 Mn |
Historic Data
Download Data
Historic Data
| Date | Value |
|---|---|
| Apr 30, 2026 | -3.43 Mn |
| Jan 31, 2026 | -2.66 Mn |
| Oct 31, 2025 | -1.98 Mn |
| Jul 31, 2025 | -3.09 Bn |
| Apr 30, 2025 | -14.14 Mn |
| Jan 31, 2025 | -19.63 Mn |
| Oct 31, 2024 | -3.50 Mn |
| Jul 31, 2024 | -4.05 Bn |
| Apr 30, 2024 | -17.56 Mn |
| Jan 31, 2024 | -3.05 Mn |
| Oct 31, 2023 | -2.21 Bn |
| Jul 31, 2023 | -3.03 Bn |
| Apr 30, 2023 | -5.82 Mn |
| Jan 31, 2023 | -3.32 Mn |
| Oct 31, 2022 | -5.53 Mn |
| Jul 31, 2022 | -7.52 Mn |
| Apr 30, 2022 | -4.19 Mn |
| Jan 31, 2022 | -3.57 Mn |
| Oct 31, 2021 | -3.88 Mn |
| Jul 31, 2021 | -2.97 Mn |